Authors:
HAYNERBUCHAN A
KALLAKURY BVS
SHEEHAN CE
MALFETANO JH
AMBROS RA
ROSS JS
Citation: A. Haynerbuchan et al., PROFILE OF CELL-PROLIFERATION ASSOCIATED PROTEINS IN ENDOMETRIAL CARCINOMAS (EC) INCLUDING PAP SEROUS (PAP), ENDOMETRIOID (EM) AND VILLOGLANDULAR (VG) SUBTYPES, Modern pathology, 11(1), 1998, pp. 104-104
Authors:
YANG F
AMBROS RA
KALLAKURY BVS
SHEEHAN CE
MALFETANO JH
MURACA PJ
ROSS JS
Citation: F. Yang et al., HER-2 NEU ONCOGENE AMPLIFICATION BY FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) IN OVARIAN NEOPLASMS/, Modern pathology, 11(1), 1998, pp. 117-117
Authors:
ASBURY R
BLESSING JA
BULLER R
MALFETANO JH
WALKER J
SEVIN BU
Citation: R. Asbury et al., AMONAFIDE IN PATIENTS WITH LEIOMYOSARCOMA OF THE UTERUS - A PHASE-II GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 21(2), 1998, pp. 145-146
Authors:
KALLAKURY BVS
AMBROS RA
HAYNERBUCHAN AM
SHEEHAN CE
MALFETANO JH
ROSS JS
Citation: Bvs. Kallakury et al., CELL PROLIFERATION-ASSOCIATED PROTEINS IN ENDOMETRIAL CARCINOMAS, INCLUDING PAPILLARY SEROUS AND ENDOMETRIOID SUBTYPES, International journal of gynecological pathology, 17(4), 1998, pp. 320-326
Authors:
RIBEN MW
MALFETANO JH
NAZEER T
MURACA PJ
AMBROS RA
ROSS JS
Citation: Mw. Riben et al., IDENTIFICATION OF HER-2 NEU ONCOGENE AMPLIFICATION BY FLUORESCENCE IN-SITU HYBRIDIZATION IN STAGE-I ENDOMETRIAL CARCINOMA/, Modern pathology, 10(8), 1997, pp. 823-831
Authors:
AMBROS RA
MALFETANO JH
CARLSON JA
MIHM MC
Citation: Ra. Ambros et al., NONNEOPLASTIC EPITHELIAL ALTERATIONS OF THE VULVA - RECOGNITION ASSESSMENT AND COMPARISONS OF TERMINOLOGIES USED AMONG THE VARIOUS SPECIALTIES, Modern pathology, 10(5), 1997, pp. 401-408
Authors:
BROUN ER
ISEMINGER KA
ROSE PG
LENTZ SL
MALFETANO JH
LINCOLN S
MANNEL R
Citation: Er. Broun et al., A PHASE-II TRIAL OF EDATREXATE IN PREVIOUSLY TREATED SQUAMOUS-CELL CERVICAL-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 20(1), 1997, pp. 78-80
Authors:
MALFETANO JH
KEYS H
CUNNINGHAM MJ
GIBBONS S
AMBROS R
Citation: Jh. Malfetano et al., EXTENDED FIELD RADIATION AND CISPLATIN FOR STAGE IIB AND IIIB CERVICAL-CARCINOMA, Gynecologic oncology, 67(2), 1997, pp. 203-207
Authors:
CUNNINGHAM MJ
GOYER RP
GIBBONS SK
KREDENTSER DC
MALFETANO JH
KEYS H
Citation: Mj. Cunningham et al., PRIMARY RADIATION, CISPLATIN, AND 5-FLUOROURACIL FOR ADVANCED SQUAMOUS CARCINOMA OF THE VULVA, Gynecologic oncology, 66(2), 1997, pp. 258-261
Authors:
RIBEN MW
SHEEHAN CE
MALFETANO JH
NAZEER T
AMBROS RA
ROOS JS
Citation: Mw. Riben et al., DETERMINATION OF HER-2 NEU AMPLIFICATION (AMP) BY FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) IN ENDOMETRIAL CARCINOMA (EC) - PROGNOSTIC VALUE COMPARED TO OTHER PATHOLOGICAL FEATURES/, Laboratory investigation, 76(1), 1997, pp. 626-626
Authors:
ROSS JS
YANG F
AMBROS RA
KALLAKURY BVS
SHEEHAN CE
MALFETANO JH
MURACA PJ
Citation: Js. Ross et al., HER-2 NEU ONCOGENE AMPLIFICATION BY FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) IN OVARIAN NEOPLASMS/, American journal of human genetics, 61(4), 1997, pp. 2131-2131
Authors:
MALFETANO JH
BLESSING JA
HOMESLEY HD
LOOK KY
MCGEHEE R
Citation: Jh. Malfetano et al., A PHASE-II TRIAL OF DIDEMNIN-B (NSC-NUMBER-335319) IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX A GYNECOLOGIC-ONCOLOGY-GROUP STUDY - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 19(2), 1996, pp. 184-186
Authors:
AMBROS RA
KALLAKURY BVS
MALFETANO JH
MIHM MC
Citation: Ra. Ambros et al., CYTOKINE, CELL-ADHESION RECEPTOR, AND TUMOR-SUPPRESSOR GENE-EXPRESSION IN VULVAR SQUAMOUS CARCINOMA - CORRELATION WITH PROMINENT FIBROMYXOID STROMAL RESPONSE, International journal of gynecological pathology, 15(4), 1996, pp. 320-325
Citation: Ra. Ambros et al., CLINICOPATHOLOGICAL FEATURES OF VULVAR SQUAMOUS-CELL CARCINOMAS EXHIBITING PROMINENT FIBROMYXOID STROMAL RESPONSE, International journal of gynecological pathology, 15(2), 1996, pp. 137-145
Citation: G. Sutton et al., IFOSFAMIDE AND DOXORUBICIN IN THE TREATMENT OF ADVANCED LEIOMYOSARCOMAS OF THE UTERUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 62(2), 1996, pp. 226-229
Authors:
CUNNINGHAM MJ
COLLINS MB
KREDENTSER DC
MALFETANO JH
Citation: Mj. Cunningham et al., PERIPHERAL INFUSION PORTS FOR CENTRAL VENOUS ACCESS IN PATIENTS WITH GYNECOLOGIC MALIGNANCIES, Gynecologic oncology, 60(3), 1996, pp. 397-399
Citation: Jh. Malfetano et al., A PHASE-II TRIAL OF GALLIUM NITRATE (NSC NUMBER-15200) IN NONSQUAMOUSCELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 18(6), 1995, pp. 495-497
Authors:
CUNNINGHAM MJ
BROMBERG C
KREDENTSER DC
COLLINS MB
MALFETANO JH
Citation: Mj. Cunningham et al., PERCUTANEOUS GASTROSTOMY FOR DECOMPRESSION IN PATIENTS WITH ADVANCED GYNECOLOGIC MALIGNANCIES, Gynecologic oncology, 59(2), 1995, pp. 273-276
Authors:
KALLAKURY BVS
AMBROS RA
ROSS JS
MALFETANO JH
KIM Y
HWANG J
FIGGE J
Citation: Bvs. Kallakury et al., P53 GENE STATUS IN ENDOMETRIAL CARCINOMAS SHOWING DIFFUSE POSITIVITY FOR P53 PROTEIN BY IMMUNOHISTOCHEMISTRY (IMH), Laboratory investigation, 72(1), 1995, pp. 91-91
Authors:
NAZEER T
BALLOUK F
MALFETANO JH
FIGGE H
AMBROS RA
Citation: T. Nazeer et al., MULTIVARIATE SURVIVAL ANALYSIS OF CLINICOPATHOLOGICAL FEATURES IN SURGICAL STAGE-I ENDOMETRIOID CARCINOMA INCLUDING ANALYSIS OF HER-2 NEU EXPRESSION/, American journal of obstetrics and gynecology, 173(6), 1995, pp. 1829-1834
Authors:
NAZEER T
CHURCH K
AMATO C
AMBROS RA
ROSANO TG
MALFETANO JH
ROSS JS
Citation: T. Nazeer et al., METHODS IN PATHOLOGY - COMPARATIVE QUANTITATIVE IMMUNOHISTOCHEMICAL AND IMMUNORADIOMETRIC DETERMINATIONS OF CATHEPSIN-D IN ENDOMETRIAL ADENOCARCINOMA - PREDICTORS OF TUMOR AGGRESSIVENESS, Modern pathology, 7(4), 1994, pp. 469-474
Citation: Ra. Ambros et al., SIGNIFICANCE OF PAPILLARY (VILLOGLANDULAR) DIFFERENTIATION IN ENDOMETRIOID CARCINOMA OF THE UTERUS, The American journal of surgical pathology, 18(6), 1994, pp. 569-575
Authors:
SUTTON GP
BLESSING JA
HOMESLEY HD
MALFETANO JH
Citation: Gp. Sutton et al., A PHASE-II TRIAL OF IFOSFAMIDE AND MESNA IN PATIENTS WITH ADVANCED ORRECURRENT MIXED MESODERMAL TUMORS OF THE OVARY PREVIOUSLY TREATED WITH PLATINUM-BASED CHEMOTHERAPY - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 53(1), 1994, pp. 24-26